scholarly journals Effect of day of the week on short- and long-term mortality after emergency general surgery

2017 ◽  
Vol 104 (7) ◽  
pp. 936-945 ◽  
Author(s):  
M. A. Gillies ◽  
N. I. Lone ◽  
R. M. Pearse ◽  
C. Haddow ◽  
L. Smyth ◽  
...  
2020 ◽  
Vol 50 (8) ◽  
pp. 977-984 ◽  
Author(s):  
Amit Akirov ◽  
Alexander Gorshtein ◽  
Chagit Adler‐Cohen ◽  
Tali Steinmetz ◽  
Tzipora Shochat ◽  
...  

2011 ◽  
Vol 253 (2) ◽  
pp. 393-401 ◽  
Author(s):  
Ryan R. Davies ◽  
Mark J. Russo ◽  
Kimberly N. Hong ◽  
Seema Mital ◽  
Ralph S. Mosca ◽  
...  

2000 ◽  
Vol 36 (4) ◽  
pp. 1194-1201 ◽  
Author(s):  
Edward L Hannan ◽  
Michael J Racz ◽  
Djavad T Arani ◽  
Thomas J Ryan ◽  
Gary Walford ◽  
...  

Angiology ◽  
2018 ◽  
Vol 70 (5) ◽  
pp. 431-439 ◽  
Author(s):  
Yalcin Velibey ◽  
Tolga Sinan Guvenc ◽  
Koray Demir ◽  
Ahmet Oz ◽  
Evliya Akdeniz ◽  
...  

We retrospectively analyzed short- and long-term outcomes of patients who received bailout tirofiban during primary percutaneous intervention (pPCI). A total of 2681patients who underwent pPCI between 2009 and 2014 were analyzed; 1331 (49.6%) out of 2681 patients received bailout tirofiban. Using propensity score matching, 2100 patients (1050 patient received bail-out tirofiban) with similar preprocedural characteristics were identified. Patients who received bailout tirofiban had a significantly higher incidence of acute stent thrombosis, myocardial infarction, and major cardiac or cerebrovascular events during the in-hospital period. There were numerically fewer deaths in the bailout tirofiban group in the unmatched cohort (1.7% vs 2.5%, P = .118). In the matched cohort, in-hospital mortality was significantly lower (1.1% vs 2.4%, P = .03), and survival at 12 and 60 months were higher (96.9% vs 95.2%, P = .056 for 12 months and 95.1% vs 92.0%, P = .01 for 60 months) in the bailout tirofiban group. After multivariate adjustment, bailout tirofiban was associated with a lower mortality at 12 months (odds ratio [OR]: 0.554, 95% confidence interval [CI], 0.349-0.880, P = .012) and 60 months (OR: 0.595, 95% CI, 0.413-0.859, P = .006). In conclusion, bailout tirofiban strategy during pPCI is associated with a lower short- and long-term mortality, although in-hospital complications were more frequent.


2018 ◽  
Vol 20 (12) ◽  
Author(s):  
Rajesh Gupta ◽  
Dylan D. Fortman ◽  
Daniel R. Morgenstern ◽  
Christopher J. Cooper

Sign in / Sign up

Export Citation Format

Share Document